Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sona NanotechSNANF -5.12%26 3-Year EBITDA Growth Rate is 11.70% as of Apr. 2026, which is 34% above its 10-year median of 8.70. GuruFocus rates SNANF with a GF Score™ of 26/100. The stock has 1 warning sign investors should review. Among 1,127 Biotechnology companies, Sona Nanotech ranks worse than 53.95% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 11.70% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 33.80% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 1.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sona Nanotech was 59.40% per year. The lowest was -152.00% per year. And the median was 8.70% per year.
Sona Nanotech (OTCPK:SNANF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Sona Nanotech 3-Year EBITDA Growth Rate Related Terms
SNANF vs VRTX, REGN, MRNA: 3-Year EBITDA Growth Rate Comparison
For the Biotechnology subindustry, Sona Nanotech's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sona Nanotech 3-Year EBITDA Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sona Nanotech's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Sona Nanotech's 3-Year EBITDA Growth Rate falls into.
Sona Nanotech 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 11.70% mean?
Sona Nanotech (SNANF) has a 3-Year EBITDA Growth Rate of 11.70% as of Apr. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Sona Nanotech and its competitors. This is 34% above median its historical median of 8.70. According to the industry distribution chart, Sona Nanotech ranks #608 out of 1127 companies in the Biotechnology industry, placing it in the top 53.9%.
Is Sona Nanotech's 3-Year EBITDA Growth Rate too high?
Sona Nanotech's current 3-Year EBITDA Growth Rate of 11.70% is 34% above median its 10-year median of 8.70. The Biotechnology industry median 3-Year EBITDA Growth Rate is 14.60. Sona Nanotech's value of 11.70% is 19.9% below this industry median. Based on the distribution chart, Sona Nanotech ranks #608 out of 1127 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Sona Nanotech has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Sona Nanotech's 3-Year EBITDA Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sona Nanotech ranks #608 out of 1127 companies for 3-Year EBITDA Growth Rate. This places Sona Nanotech in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 14.60. Sona Nanotech's value of 11.70% is 19.9% below this benchmark. While the company's 10-year median is 8.70 vs. the industry median of 14.60, Sona Nanotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Biotechnology company?
The median 3-Year EBITDA Growth Rate among Biotechnology companies is 14.60, based on 1,127 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sona Nanotech's current 3-Year EBITDA Growth Rate of 11.70% is 19.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Sona Nanotech and its competitors. For the Biotechnology industry, the median 3-Year EBITDA Growth Rate is 14.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sona Nanotech's current 3-Year EBITDA Growth Rate is 11.70%, which is 34% above median its own 10-year median of 8.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sona Nanotech stock overvalued right now?
Sona Nanotech (SNANF) has a current 3-Year EBITDA Growth Rate of 11.70%. The current 3-Year EBITDA Growth Rate is 11.70%, which is 34% above median its 10-year median of 8.70 and 19.9% below the Biotechnology industry median of 14.60. Sona Nanotech's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Sona Nanotech (SNANF), the current 3-Year EBITDA Growth Rate is 11.70% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sona Nanotech Inc is involved in the nanotechnology life sciences industry. It has developed two proprietary methods for the manufacture of rod-shaped gold nanoparticles and is engaged in the research and development of its proprietary technology for use in biomedical applications and multiplex diagnostic testing platforms. The company is using its gold nano rods manufacturing technology to develop new products and methods for cancer treatment, including a Targeted Hyperthermia Therapy (THT). Additionally, it has filed patent applications in the U.S. regarding a gold nanorod conjugation concept for targeted drug delivery, combination therapies for treating cancer, and for an endoscope with an optical fibre and thermal sensor for photothermal therapy.
26GF Score
Get the complete analysis for SNANF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNANF has been successfully added to your 
